| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H31NO |
| Molar mass | 361.529 g·mol−1 |
| 3D model (JSmol) | |
| |
Butaclamol (AY-23,028) is a type of antipsychotic which was never marketed. [1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist. [2]
pKa = 7.15 (uncorrected for ionic strength) [6]
| σ1 |
|
|---|---|
| σ2 |
|
| Unsorted |
|
See also: Receptor/signaling modulators | |
| Classes | |
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs)) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Anticholinergics | |
| Others | |
| | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |